NU Hospital Group-Vaestra Goetalandsregionen

Clinical research activity is centred on type 1 diabetes, with attention to newly diagnosed patients and the preservation of residual insulin secretion. The funded trial addresses immune-mediated disease processes in early diabetes and the clinical course of beta-cell function.

• Newly diagnosed type 1 diabetes
• Residual insulin secretion
• Beta-cell function

Interest in this area reflects a focus on metabolic and immunologic aspects of diabetes care within a hospital-based research setting.